US Stock MarketDetailed Quotes
AEMD Aethlon Medical
- 0.4344
- +0.0300+7.42%
Close Jul 11 16:00 ET
- 0.4201
- -0.0143-3.29%
Post 19:58 ET
6.04MMarket Cap-89P/E (TTM)
0.4625High0.4100Low2.03MVolume0.4100Open0.4044Pre Close879.24KTurnover14.82%Turnover RatioLossP/E (Static)13.90MShares4.380052wk High1.05P/B5.94MFloat Cap0.370452wk Low--Dividend TTM13.68MShs Float67499.9865Historical High--Div YieldTTM12.98%Amplitude0.3704Historical Low0.4330Avg Price1Lot Size
Aethlon Medical Stock Forum
Sign in to post a comment
$Aethlon Medical(AEMD.US$ hopeless
1
$Aethlon Medical(AEMD.US$ don't worry it's friday + earning fall nothing to stress 💎
2
$Aethlon Medical(AEMD.US$
Aethlon Medical (Nasdaq: AEMD) announced financial results for the fiscal year ending March 31, 2024, and provided a corporate update. The company continues the clinical development of its Hemopurifier® for cancer and infectious diseases, receiving ethics approval for a clinical trial in Australia.
Financially, Aethlon reported a net loss of $12.2 million, a slight increase from the previous year's $12 million.
Operating expenses rose marginally to $12.6 milli...
Aethlon Medical (Nasdaq: AEMD) announced financial results for the fiscal year ending March 31, 2024, and provided a corporate update. The company continues the clinical development of its Hemopurifier® for cancer and infectious diseases, receiving ethics approval for a clinical trial in Australia.
Financially, Aethlon reported a net loss of $12.2 million, a slight increase from the previous year's $12 million.
Operating expenses rose marginally to $12.6 milli...
4
$Aethlon Medical(AEMD.US$ buy the dip! and let it rip!
$Aethlon Medical(AEMD.US$ sec 201 will be active tommorow if i'm not wrong!
3
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial.
Aethlon Medical, Inc. (Nasdaq: AEMD), a pioneering medical therapeutic company dedicated to developing advanced treatments for cancer and life-threatening infectious diseases, has reached a milestone in its quest to improve cancer therapy outcomes. On June 13, 2024, the Human Research Ethics Committee (HREC) of the Central Adelaide Local Healt...
Aethlon Medical, Inc. (Nasdaq: AEMD), a pioneering medical therapeutic company dedicated to developing advanced treatments for cancer and life-threatening infectious diseases, has reached a milestone in its quest to improve cancer therapy outcomes. On June 13, 2024, the Human Research Ethics Committee (HREC) of the Central Adelaide Local Healt...
6
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
安安稳稳过日子 :